Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Wei-Ze Hung"'
Autor:
Wei-Ze Hung, Zhi Xuan Law, De-Hao Tsai, Bing-Hung Chen, Chao-Huang Chen, Hsi-Yen Hsu, Yung-Tin Pan
Publikováno v:
MRS Energy & Sustainability. 9:342-349
Autor:
K.S. Clifford Chao, William Tzu-Liang Chen, Pei-Chen Yang, An-Cheng Shiau, Ji-An Liang, Tao-Wei Ke, Shu-Fen Chiang, Pei-Chun Lin, Hsin-Yu Chang, Wei-Ze Hung, Chia-Ying Lai, Kevin Chih-Yang Huang
Supplementary Figures S1-S6 and Tables S1-S3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ddeead477ca5c5c3b6f1b76cee05e27
https://doi.org/10.1158/2326-6066.22546229.v1
https://doi.org/10.1158/2326-6066.22546229.v1
Autor:
K.S. Clifford Chao, William Tzu-Liang Chen, Pei-Chen Yang, An-Cheng Shiau, Ji-An Liang, Tao-Wei Ke, Shu-Fen Chiang, Pei-Chun Lin, Hsin-Yu Chang, Wei-Ze Hung, Chia-Ying Lai, Kevin Chih-Yang Huang
The potency of tumor-specific antigen (TSA) vaccines, such as neoantigen (neoAg)-based cancer vaccines, can be compromised by host immune checkpoint inhibitory mechanisms, such as programmed cell death protein 1 (PD-1)/programmed death ligand 1 (PD-L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::197622b6861e8d3f78c52ae19c519200
https://doi.org/10.1158/2326-6066.c.6551129
https://doi.org/10.1158/2326-6066.c.6551129
Autor:
Kevin Chih-Yang Huang, Chia-Ying Lai, Wei-Ze Hung, Hsin-Yu Chang, Pei-Chun Lin, Shu-Fen Chiang, Tao-Wei Ke, Ji-An Liang, An-Cheng Shiau, Pei-Chen Yang, William Tzu-Liang Chen, K.S. Clifford Chao
Publikováno v:
Cancer immunology research. 11(1)
The potency of tumor-specific antigen (TSA) vaccines, such as neoantigen (neoAg)-based cancer vaccines, can be compromised by host immune checkpoint inhibitory mechanisms, such as programmed cell death protein 1 (PD-1)/programmed death ligand 1 (PD-L
Autor:
Tsung-Wei Chen, Wei-Ze Hung, Shu-Fen Chiang, William Tzu-Liang Chen, Tao-Wei Ke, Ji-An Liang, Chih-Yang Huang, Pei-Chen Yang, Kevin Chih-Yang Huang, K.S. Clifford Chao
Publikováno v:
Cancer Letters. 543:215795
TGFβ contributes to chemoresistance in advanced colorectal cancer (CRC) via diverse immune-microenvironment mechanisms. Here, we found that cancer cell autonomous TGFβ directly triggered tumor programmed cell death 1 ligand 1 (PD-L1) upregulation,